Abstract
Breast cancer is the commonest malignancy diagnosed in women. Although there have been huge advances in treatment in recent years leading to excellent outlooks for many women, a significant number of patients are developing bone complications. This is often due to metastatic bone disease, which occurs in approximately 70% of women with advanced breast cancer. Additionally, accelerated bone loss and associated complications such as fractures may be a consequence of adjuvant treatment. Whatever the cause, cancer-induced bone disease can have potentially devastating clinical consequences for the patient, and results in a considerable economic burden to the health care provider. This review addresses the causes and sequelae of bone disease in both early and advanced breast cancer. The evidence for preserving bone health, both with traditional treatments such as bisphosphonates and newer agents, including antibody therapy is reviewed, with recommendations for current practice. Finally, we discuss the emerging potential role of bone-targeting therapies in preventing the development of metastatic disease.
References
May 10, 2001·Bone·H L BenfordM J Rogers
Aug 3, 2002·Nature Reviews. Cancer·Gregory R Mundy
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J BodyUNKNOWN MF 4265 Study Group
Oct 10, 2003·Cancer·Lee S RosenJohn J Seaman
Jun 16, 2004·Cancer·Lee S RosenJohn Seaman
Sep 15, 2004·Pain·Jean-Jacques BodyBengt Bergström
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Helen L Neville-WebbeIngunn Holen
Apr 26, 2005·Cancer Treatment Reviews·James LesterRobert Coleman
Sep 21, 2005·Endocrine-related Cancer·G A Clines, T A Guise
Nov 30, 2005·The Oncologist·Valentina GuarneriPier Franco Conte
Aug 2, 2006·The Oncologist·Giacomo CartenìDino Amadori
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Aug 1, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sundeep KhoslaUNKNOWN American Society for Bone and Mineral Research
Oct 5, 2007·The Oncologist·Allan LiptonRobert E Coleman
May 22, 2008·Cancer Treatment Reviews
Jun 3, 2008·Cancer Treatment Reviews·David M ReidRobert E Coleman
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie L HinesEdith A Perez
Sep 5, 2009·Current Opinion in Oncology·Matthew C Winter, Robert E Coleman
Jan 12, 2010·Gynecologic Oncology·Antonis ValachisDavide Mauri
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine Van PoznakRichard Eastell
Feb 20, 2010·Current Pharmaceutical Design·Ingunn Holen, Robert E Coleman
Citations
Sep 8, 2012·Clinical & Experimental Metastasis·Louis Doré-SavardPhilippe Sarret
Aug 27, 2013·The Breast : Official Journal of the European Society of Mastology·James ClearyBenjamin O Anderson
Aug 8, 2018·BMC Musculoskeletal Disorders·Joseph K KendalMichael J Monument
Jul 12, 2020·BMC Cancer·L AbsilD Nonclercq
Sep 29, 2018·International Journal of Molecular Sciences·Hannah K BrownIngunn Holen
Jan 1, 2015·BoneKEy Reports·Koen RaymaekersGeert Carmeliet
Dec 11, 2020·Neuro-oncology Practice·Joshua T Wewel, John E O'Toole